US4892883A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Pharmaceutical compositions containing bilobalide for the treatment of neuropathies Ai
Assignee: Dr Willmar Schwabe GmbH and Co KG
•
Filing: 1988-10-11
•
Granted: 1990-01-09
•
Expires: 2008-10-11
Abstract
Abstract Medicaments containing bilobalide which can be used to control nervous diseases are described.
Inventors
- 👤 Shyam S. Chatterjee
- 👤 Benard L. Gabard
- 👤 Hermann E. W. Jaggy
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 10:36
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/335; A61K31/365; A61P; A61P25/00; A61P25/18; A61P25/28
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
38 words
A pharmaceutical composition useful for the treatment of neuropathic disorders which comprises a combination of flavone glycosides and bilobalide in a pharmaceutical carrier wherein the concentration of bilobalide and flavone glycosides are cooperatively sufficient to alleviate neuropathic disorders.
Claim 2
Dependent Claim
38 words
A pharmaceutical composition useful for the treatment of neuropathic disorders which comprises a combination of flavone glycosides and bilobalide in a pharmaceutical carrier wherein the concentration of bilobalide and flavone glycosides are cooperatively sufficient to alleviate neuropathic disorders.
Claim 3
Dependent Claim
33 words
The pharmaceutical composition according to claim 1 which is a whole extract of the leaves of ginkgo bilboa, the extract containing flavone glycosides and bilobalide in amounts cooperatively sufficient to alleviate neuropathic disorders.
Claim 4
Dependent Claim
30 words
The pharmaceutical composition according to claim 1 wherein the content of bilbobalide is from 0.5 to 10 mg and the Ginko biloba monoextract content is 25 mg. to 100 mg.
Claim 5
Dependent Claim
29 words
The pharmaceutical composition according to claim 3 wherein the content of bilobalide is from about 0.5% to about 40% and residual monoextract of Ginko biloba from 99.5% to 60%.
Claim 6
Dependent Claim
29 words
The pharmaceutical composition according to claim 3 wherein the content of bilobalide is from about 3% to about 20% and residual monoextract of Ginkgo biloba from 97% to 80%.
Claim 7
Dependent Claim
20 words
The pharmaceutical composition according to claim 1 wherein the neuropathic disorders are demyelinating neuropathies, encephalopathies and myelopathies or cerebral oedemas.
Claim 8
Dependent Claim
20 words
The pharmaceutical composition according to claim 2 wherein the neuropathic disorders are demyelinating neuropathies, encephalopathies and myelopathies or cerebral oedemas.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-01-08 | 1993-07-10 | 1994-01-09 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-01-08 | 1997-07-10 | 1998-01-09 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-01-08 | 2001-07-10 | 2002-01-09 | $7700.00 | Window Closed / Lapsed |